Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression

BACKGROUND: Renal Cell Carcinoma (RCC) is difficult to treat with 5-year survival rate of 10% in metastatic patients. Main reasons of therapy failure are lack of validated biomarkers and scarce knowledge of the biological processes occurring during RCC progression. Thus, the investigation of mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooley, Lindsay S., Rudewicz, Justine, Souleyreau, Wilfried, Emanuelli, Andrea, Alvarez-Arenas, Arturo, Clarke, Kim, Falciani, Francesco, Dufies, Maeva, Lambrechts, Diether, Modave, Elodie, Chalopin-Fillot, Domitille, Pineau, Raphael, Ambrosetti, Damien, Bernhard, Jean-Christophe, Ravaud, Alain, Négrier, Sylvie, Ferrero, Jean-Marc, Pagès, Gilles, Benzekry, Sebastien, Nikolski, Macha, Bikfalvi, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527701/
https://www.ncbi.nlm.nih.gov/pubmed/34670568
http://dx.doi.org/10.1186/s12943-021-01416-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527701/
https://www.ncbi.nlm.nih.gov/pubmed/34670568
http://dx.doi.org/10.1186/s12943-021-01416-5

Ejemplares similares